Biotech Stock With Covid Solution Offering 'A Huge Potential'

Modern Value Investing with Sven Carlin

Biotech stocks are always risky and in this video, using the example of Marinomed Biotech stock that is working with nasal spays, not profitable and really small, I wish to explain the risks and rewards of investing in such companies. I understand the hopes that can be created when a management promises scaling, growth, high margins and a cure to some disease, but then again burning twice as much cash as you make in revenue should be a thing to take into consideration. There are many words that are often used with stocks that promise a lot, so be sure to check the facts really good before investing. Your best friend is Google and look for confirmations on what is the management selling. So, when it comes to biotech stock prices, it all depends on whether the product will ever get traction. However, a market cap of 136 million EUR on 5 million of sea weed sales is remarkable! Want to know more about what I do? https://goo.gl/MQG2k5 Full-time independent stock market analyst and researcher! STOCK MARKET RESEARCH PLATFORM (analysis, stocks to buy, model portfolio) Stock Ideas and Analyses for The Small Investor: https://goo.gl/GdKEoe I am also a book author: Modern Value Investing book: https://amzn.to/2lvfH3t More at the Sven Carlin blog: https://svencarlin.com/ Check out Modern Value Investing YouTube: https://www.youtube.com/c/InvestwithSvenCarlinPhD